
Jupiter Life Line Hospitals Limited Announces Record Date for Equity Share Split
Jupiter Life Line Hospitals Limited has announced the record date for the sub-division and split of its existing equity shares. The company has scheduled Friday, July 24, 2026, as the cut-off date to determine the eligibility of shareholders entitled to participate in the stock split.The decision follows the approval received from equity shareholders during the Annual General Meeting conducted on July 17, 2026. The company confirmed that the share split will involve a conversion of face values to ensure a broader distribution of shares among the shareholder base.
| Feature | Pre-Split Details | Post-Split Details |
|---|---|---|
| Number of Shares | 1 Share | 5 Shares |
| Face Value per Share | ₹10 | ₹2 |
Each existing equity share with a face value of ₹10 fully paid-up will be sub-divided into 5 equity shares. Each of the new shares will carry a face value of ₹2 and will rank pari passu in all respects with the original shares.
The company previously provided updates regarding this initiative on May 15, 2026, and June 22, 2026. This corporate action is part of the company's ongoing structural adjustments to its equity share capital structure as approved by the shareholders during the July proceedings.
JLHL Stock Price Movement
Jupiter Life Line Hospitals Limited shares are edging higher to ₹1555.00 as of 2:11 PM today, gaining 0.06% in live trading. The stock is seeing steady activity with a current volume of 18,268 shares traded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.